Inventor · disambiguated record
David A. Sallman
Also filed as: SALLMAN DAVID A
2 granted patents·2 pending applications·12 citations·filing 2015–2022
57Inventor score
Top patents by PatentIndex Score
4 records- 0186US10071094B2Protein phosphatase 2A inhibitors for treating myelodysplastic syndromesH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Sep 11, 2018·7 cites·19 claims
- 0284US10434100B2Protein phosphatase 2A inhibitors for treating myelodysplastic syndromesH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 8, 2019·5 cites·20 claims
- 0357US2022323433A2Clinical regimen for treating myelodysplastic syndrome with phosphatase inhibitorLIST ALAN F·Filed 2022·Application pending·0 cites
- 0453US2019111053A1Clinical regimen for treating myelodysplastic syndrome with phosphatase inhibitorLIXTE BIOTECHNOLOGY INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →